Anson Zhou
ansonyzhou.bsky.social
Anson Zhou
@ansonyzhou.bsky.social
MD/MBA @ Stanford | Prev. Microsoft Research, Schrödinger, Johns Hopkins | bio, health, AI
Reposted by Anson Zhou
MedAgentBench, a comprehensive benchmark designed to evaluate the agentic capabilities of large language models in realistic EHR environments, provides a critical foundation for advancing and integrating LLM agents into clinical workflows. Learn more: nejm.ai/45AUXwS

#AI #MedSky #MLSky
August 21, 2025 at 1:30 PM
Reposted by Anson Zhou
It’s finally out! We brought a multidisciplinary team of physicians, computer scientists, and engineers to red team LLMs for healthcare uses. And we have shared the dataset! www.nature.com/articles/s41...
Red teaming ChatGPT in medicine to yield real-world insights on model behavior - npj Digital Medicine
npj Digital Medicine - Red teaming ChatGPT in medicine to yield real-world insights on model behavior
www.nature.com
March 7, 2025 at 6:46 PM
Reposted by Anson Zhou
Francis Collins, the NIH Director for 12 years, led the Human Genome Project and other NIH efforts for 32 years, resigned today. Key words from his resignation letter
www.nytimes.com/2025/03/01/u...
March 1, 2025 at 6:07 PM
Reposted by Anson Zhou
Today's @usatoday.com front page
First US death from measles in 10 years
First child to die from measles in 22 years in the US
All of this fully preventable
February 27, 2025 at 2:09 PM
Reposted by Anson Zhou
Dai and colleagues present the Clinical Behavioral Atlas, a computer vision system that can identify 40 clinically relevant activity categories and 55 object categories solely through RGB video data. Read the full article: nejm.ai/4g8D23N

#MedSky #AI #MLSky
Developing ICU Clinical Behavioral Atlas Using Ambient Intelligence and Computer Vision
While computer vision has gained traction in medical applications, models specifically engineered for intensive care unit (ICU) activities are limited. We present Clinical Behavioral Atlas (CBA), a...
nejm.ai
February 18, 2025 at 3:07 PM
Reposted by Anson Zhou
It's not "Breaking News" now, since it was announced by NIH yesterday. But it is breaking.......
washingtonpost.com/health/2025/...
February 8, 2025 at 5:16 PM
Reposted by Anson Zhou
Reposted by Anson Zhou
The authors of a Perspective set out recommendations enabling those creating and/or using health care datasets to identify and transparently acknowledge underlying biases. Read the full Perspective: nejm.ai/429WKJj

#MedSky
Tackling Algorithmic Bias and Promoting Transparency in Health Datasets: The STANDING Together Consensus Recommendations
Without careful dissection of the ways in which biases can be encoded into artificial intelligence (AI) health technologies, there is a risk of perpetuating existing health inequalities at scale. O...
nejm.ai
February 4, 2025 at 3:03 PM
Reposted by Anson Zhou
A Review in Nature Medicine explores the state-of-the-art applications of artificial intelligence in small-molecule drug development, from target identification and drug synthesis up to clinical trial design and conduct. https://go.nature.com/4jFyuVG 🔒
February 2, 2025 at 2:31 PM
Reposted by Anson Zhou
When your lab decides that this quarter’s activity is goat yoga.
February 1, 2025 at 7:58 PM
Reposted by Anson Zhou
Alibaba releases Qwen2.5-Max, an AI model that they claim is better than DeepSeek, ChatGPT, and Meta. Their stock is soaring since its release. Here is link to it qwenlm.github.io/blog/qwen2.5...
Qwen2.5-Max: Exploring the Intelligence of Large-scale MoE Model
QWEN CHAT API DEMO DISCORD It is widely recognized that continuously scaling both data size and model size can lead to significant improvements in model intelligence. However, the research and industr...
qwenlm.github.io
January 29, 2025 at 8:15 PM
Super exciting application of new outcomes-based pricing models for ultra-expensive cell & gene therapies!

Under this model, manufacturers of Casgevy ($2.2M) and Lyfgenia ($3.1M) have agreed that cost to Medicaid will be a function of drug efficacy in patients.
In Brief: bluebird bio and @vertexpharma.bsky.social are the first to participate in a scheme to enable people with sickle cell disease to access treatments they would otherwise not be able to afford nature.com/articles/s41...
rdcu.be/d7Hss
Pricey sickle cell gene therapies primed for change - Nature Biotechnology
Nature Biotechnology - Pricey sickle cell gene therapies primed for change
nature.com
January 28, 2025 at 10:40 PM
Reposted by Anson Zhou
DeepSeek is a side project 🔥
January 24, 2025 at 8:01 AM
Excited to share the most recent episode from Stanford Knight-Hennessy's "Imagine A World" podcast!

Sydney and I spoke with Christian Tanja and Jordyn Sanico (both members of the Knight-Hennessy admissions team) about their work, guiding values, and improbable facts. Enjoy :)
Empowering and Serving a Community
Imagine A World · Episode
open.spotify.com
January 22, 2025 at 5:54 PM
Reposted by Anson Zhou
A vision-language foundation #AI model for cancer from 50 million path images, a million path-text images, with high performance for predicting clinical outcomes, relapse, response to immunotherapy and other benchmarks
nature.com/articles/s41...
@nature.com (bad name for model—MUSK)
A vision–language foundation model for precision oncology - Nature
Trained on unlabelled, unpaired image and text data, the Multimodal transformer with Unified maSKed modeling excelled in outcome prediction, image-to-text retrieval and visual question answering, pote...
nature.com
January 8, 2025 at 4:18 PM
Reposted by Anson Zhou
The GLP-1 family of drugs have anti-inflammatory effects independent of weight loss.
2 new studies shed light on the mechanisms
—brain-gut-GLP axis blocks inflammation induced by TLRs (toll-like receptor)
www.cell.com/cell-metabol...
December 27, 2024 at 2:55 PM
Reposted by Anson Zhou
Week 1 in the DLab done! Just this week I went to Half Moon Bay for their holiday party, played poker with the team, held mice for the first time, saw probes enter & record the brain, and more. So much fun!
December 21, 2024 at 4:04 AM
Reposted by Anson Zhou
This publication today on multimodal #AI to accurately and precisely predict an individual's heath trajectory, in this case #Parkinson's disease, is a frontrunner for many to come
www.nature.com/articles/s41...
Personalized progression modelling and prediction in Parkinson’s disease with a novel multi-modal graph approach - npj Parkinson's Disease
npj Parkinson's Disease - Personalized progression modelling and prediction in Parkinson’s disease with a novel multi-modal graph approach
www.nature.com
December 1, 2024 at 5:13 PM
Reposted by Anson Zhou
🧬🖥🧪 Here are some healthy reminders on just how much Illumina still dominates the #genomics space... 😐
November 27, 2024 at 6:11 PM
Reposted by Anson Zhou
It would be a real dereliction of duty to our nation's children to invite the return of vaccine-preventable diseases. Bringing polio, measles, diphtheria, under control is something we have been working on for a century -- successfully.
November 29, 2024 at 6:25 PM